• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Clene Inc. - Common Stock (NQ:CLNN)

    4.010 -0.030 (-0.74%)
    Streaming Delayed Price Updated: 12:30 PM EST, Feb 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Clene Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    Landmark Study Shows How Menopause Influences the Symptoms of Multiple Sclerosis
    Via Investor Brand Network
    BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Presents Positive REPAIR-MS Results at ECTRIMS 2025
    Via Investor Brand Network
    New Smart Pen Shows 96% Efficacy in Detecting Parkinson’s Disease
    Via Investor Brand Network
    Clene Inc.’s (NASDAQ: CLNN) Lead Candidate CNM-Au8(R) Shows Promise in Improving Cellular Health in Parkinson’s Disease
    Via Investor Brand Network
    MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Toward NDA Submission for ALS Therapy
    Via Investor Brand Network
    BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Presents Preclinical Data Showing CNM-Au8 Improves Cellular Health in Parkinson’s Disease Model
    Via Investor Brand Network
    Research Uncovers Possible Way to Repair Myelin in MS Patients
    Via Investor Brand Network
    BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at H.C. Wainwright Global Investment Conference
    Via Investor Brand Network
    InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Late-Stage Momentum in Neuro Pipeline
    Via Investor Brand Network
    Pioneering Therapy Could Slow the Effects of Aging
    Via Investor Brand Network
    Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
    Via Investor Brand Network
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results, Targets Year-End NDA Submission for ALS Therapy
    Via Investor Brand Network
    News headline image
    Clene Posts 70% Revenue Drop in Q2 ↗
    Via The Motley Fool
    InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20
    Via Investor Brand Network
    Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option
    Via Investor Brand Network
    BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference
    Via Investor Brand Network
    New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease
    Via Investor Brand Network
    Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate
    Via Investor Brand Network
    BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients
    Via Investor Brand Network
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    Individuals Who Develop Multiple Sclerosis Have More Doctor Visits Decades Before Their Diagnosis
    Via Investor Brand Network
    Preclinical Study Finds a Way to Reverse Symptoms of Parkinson’s in Mice
    Via Investor Brand Network
    Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
    Via Investor Brand Network
    BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
    Via Investor Brand Network
    Why Public Interest in Mitochondrial Function Testing is Growing
    Via Investor Brand Network
    News headline image
    Q2 Virtual Investor Summit: Presentations Available Now
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.